Acadia Pharmaceuticals, INC.

Biopharmaceutical company.

Based in CA

🤖

AI Overview

With $1.4M in lobbying spend across 17 quarterly filings, Acadia Pharmaceuticals, INC. is a significant lobbying presence.

$1.4M
Total Lobbying Spend
17
Quarterly Filings
1
Lobbying Firms Used
7
Individual Lobbyists

Spending by Year

YearLobbying Spend
2021$320K
2022$320K
2023$320K
2024$240K
2025$160K

Lobbying Firms

TIBER CREEK GROUP

What They Lobby For

  • Issues affecting the pharmaceutical industry.
  • Issues related to the U.S. Food and Drug Administration (FDA); Issues related to drug pricing; Issues related to Medicare reform.
  • Issues related to the U.S. Food and Drug Administration (FDA); Issues related to drug pricing; Issues related to nursing home quality measurement.
  • Issues related to drug pricing in H.R. 5376 - the Build Back Better Act; Issues related to nursing home quality measurement.
  • Issues related to drug pricing pricing reforms; Issues related to nursing home quality measurement and broader nursing home reforms.
  • Issues related to drug pricing reforms; Issues related to nursing home quality measurement and broader nursing home reforms.
  • Issues related to drug pricing pricing reforms; Issues related to nursing home quality measurement and broader nursing home reforms; Inflation Reduction Act of 2022 (PL 117-169).
  • Issues related to drug pricing reforms; Issues related to nursing home quality measurement and broader nursing home reforms; Inflation Reduction Act of 2022 (PL 117-169).
  • Issues related to drug pricing reforms; Issues related to nursing home quality measurement and broader nursing home reforms. Inflation Reduction Act of 2022 (PL 117-169). Issues related to prescription drugs and the Food and Drug Administration in Consolidated Appropriations Act, 2023 (PL 117-328).
  • Issues related to drug pricing reforms; Issues related to nursing home quality measurement and broader nursing home reforms. Inflation Reduction Act of 2022 (PL 117-169).

Related Investigations

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.